Cargando…
The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy
The global pandemic of COVID-19 has caused huge causality and unquantifiable loss of social wealth. The innate immune response is the first line of defense against SARS-CoV-2 infection. However, strong inflammatory response associated with dysregulation of innate immunity causes severe acute respira...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063252/ https://www.ncbi.nlm.nih.gov/pubmed/35505345 http://dx.doi.org/10.1186/s12929-022-00811-4 |
_version_ | 1784699125833400320 |
---|---|
author | Wang, Yiran Wu, Mandi Li, Yichen Yuen, Ho Him He, Ming-Liang |
author_facet | Wang, Yiran Wu, Mandi Li, Yichen Yuen, Ho Him He, Ming-Liang |
author_sort | Wang, Yiran |
collection | PubMed |
description | The global pandemic of COVID-19 has caused huge causality and unquantifiable loss of social wealth. The innate immune response is the first line of defense against SARS-CoV-2 infection. However, strong inflammatory response associated with dysregulation of innate immunity causes severe acute respiratory syndrome (SARS) and death. In this review, we update the current knowledge on how SARS-CoV-2 modulates the host innate immune response for its evasion from host defense and its corresponding pathogenesis caused by cytokine storm. We emphasize Type I interferon response and the strategies of evading innate immune defense used by SARS-CoV-2. We also extensively discuss the cells and their function involved in the innate immune response and inflammatory response, as well as the promises and challenges of drugs targeting excessive inflammation for antiviral treatment. This review would help us to figure out the current challenge questions of SARS-CoV-2 infection on innate immunity and directions for future studies. |
format | Online Article Text |
id | pubmed-9063252 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90632522022-05-03 The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy Wang, Yiran Wu, Mandi Li, Yichen Yuen, Ho Him He, Ming-Liang J Biomed Sci Review The global pandemic of COVID-19 has caused huge causality and unquantifiable loss of social wealth. The innate immune response is the first line of defense against SARS-CoV-2 infection. However, strong inflammatory response associated with dysregulation of innate immunity causes severe acute respiratory syndrome (SARS) and death. In this review, we update the current knowledge on how SARS-CoV-2 modulates the host innate immune response for its evasion from host defense and its corresponding pathogenesis caused by cytokine storm. We emphasize Type I interferon response and the strategies of evading innate immune defense used by SARS-CoV-2. We also extensively discuss the cells and their function involved in the innate immune response and inflammatory response, as well as the promises and challenges of drugs targeting excessive inflammation for antiviral treatment. This review would help us to figure out the current challenge questions of SARS-CoV-2 infection on innate immunity and directions for future studies. BioMed Central 2022-05-03 /pmc/articles/PMC9063252/ /pubmed/35505345 http://dx.doi.org/10.1186/s12929-022-00811-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Wang, Yiran Wu, Mandi Li, Yichen Yuen, Ho Him He, Ming-Liang The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy |
title | The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy |
title_full | The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy |
title_fullStr | The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy |
title_full_unstemmed | The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy |
title_short | The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy |
title_sort | effects of sars-cov-2 infection on modulating innate immunity and strategies of combating inflammatory response for covid-19 therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063252/ https://www.ncbi.nlm.nih.gov/pubmed/35505345 http://dx.doi.org/10.1186/s12929-022-00811-4 |
work_keys_str_mv | AT wangyiran theeffectsofsarscov2infectiononmodulatinginnateimmunityandstrategiesofcombatinginflammatoryresponseforcovid19therapy AT wumandi theeffectsofsarscov2infectiononmodulatinginnateimmunityandstrategiesofcombatinginflammatoryresponseforcovid19therapy AT liyichen theeffectsofsarscov2infectiononmodulatinginnateimmunityandstrategiesofcombatinginflammatoryresponseforcovid19therapy AT yuenhohim theeffectsofsarscov2infectiononmodulatinginnateimmunityandstrategiesofcombatinginflammatoryresponseforcovid19therapy AT hemingliang theeffectsofsarscov2infectiononmodulatinginnateimmunityandstrategiesofcombatinginflammatoryresponseforcovid19therapy AT wangyiran effectsofsarscov2infectiononmodulatinginnateimmunityandstrategiesofcombatinginflammatoryresponseforcovid19therapy AT wumandi effectsofsarscov2infectiononmodulatinginnateimmunityandstrategiesofcombatinginflammatoryresponseforcovid19therapy AT liyichen effectsofsarscov2infectiononmodulatinginnateimmunityandstrategiesofcombatinginflammatoryresponseforcovid19therapy AT yuenhohim effectsofsarscov2infectiononmodulatinginnateimmunityandstrategiesofcombatinginflammatoryresponseforcovid19therapy AT hemingliang effectsofsarscov2infectiononmodulatinginnateimmunityandstrategiesofcombatinginflammatoryresponseforcovid19therapy |